排序酶A
共价键
半胱氨酸
分拣酶
金黄色葡萄球菌
对接(动物)
化学
活动站点
组合化学
细胞毒性
虚拟筛选
立体化学
生物化学
酶
药物发现
细菌
生物
细菌蛋白
有机化学
医学
遗传学
护理部
体外
基因
作者
Kristaps Jaudzems,Viktorija Kurbatska,Atis Jēkabsons,Raitis Bobrovs,Zhanna Rudevica,Ainars Leonchiks
标识
DOI:10.1021/acsinfecdis.9b00265
摘要
Because of its essential role as a bacterial virulence factor, enzyme sortase A (SrtA) has become an attractive target for the development of new antivirulence drugs against Gram-positive infections. Here we describe 27 compounds identified as covalent inhibitors of Staphylococcus aureus SrtA by screening a library of approximately 50 000 compounds using a FRET assay followed by NMR-based validation and binding reversibility analysis. Nineteen of these compounds displayed only moderate to weak cytotoxicity, with CC50 against NIH 3T3 mice fibroblast cells ranging from 12 to 740 μM. Analysis using covalent docking suggests that the inhibitors initially associate via hydrophobic interactions, followed by covalent bond formation between the SrtA active site cysteine and an electrophilic center of the inhibitor. The compounds represent good starting points that have the potential to be developed into broad spectrum antivirulence agents as exemplified by hit-to-lead optimization of one of the compounds.
科研通智能强力驱动
Strongly Powered by AbleSci AI